New Statin-CBD combo drug enters first human safety trial
Disease control
Completed
This early-stage study tested the safety of Atorvo+™, a new drug that combines the common cholesterol-lowering medication atorvastatin with cannabidiol (CBD). The trial involved 24 healthy adults aged 40-75 to see how the body processes the drug and if it causes any side effects.…
Phase: PHASE1 • Sponsor: Indication Bioscience LLC • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC